Sign In
Get Clay Free →

Suggestions

    Debora Barton

    Chief Medical Officer at Carisma Therapeutics

    Debora Barton, M.D., is a clinical oncologist with nearly two decades of experience in global clinical research and development.12 She served as the Chief Medical Officer at Carisma Therapeutics Inc., where she was responsible for clinical development, clinical operations, medical affairs, and safety.23

    Dr. Barton's career includes:

    • Senior Vice President, Head of Clinical, Head of Safety at Iovance Biotherapeutics, Inc., overseeing Phase 2 studies in solid tumors2
    • Positions at Advanced Accelerator Applications S.A., Celgene Corporation, and Novartis2
    • Nine years of clinical practice as an oncologist3

    She holds an M.D. from Pontificia Universidade Catolica Sao Paulo and completed her fellowship in oncology at Federal University of Sao Paulo in Brazil.12 Dr. Barton is board-certified in clinical oncology and serves on the boards of the American Cancer Society, Tigerlily Foundation (medical advisory board), and Arovella Therapeutics Ltd (non-executive director).2

    As of January 2025, Dr. Barton is no longer with Carisma Therapeutics. She is currently the Chief Medical Officer at TScan Therapeutics, a position she has held since July 2022.12

    Related Questions

    What are Debora Barton's key achievements at Carisma Therapeutics?
    How did Debora Barton's role at Iovance Biotherapeutics prepare her for her position at TScan Therapeutics?
    What specific challenges did Debora Barton face during her time at Carisma Therapeutics?
    How does Debora Barton's expertise in cell therapies benefit TScan Therapeutics?
    What are the main projects Debora Barton is currently working on at TScan Therapeutics?
    Debora Barton
    Add to my network

    Location

    Philadelphia, Pennsylvania, United States